9 results
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... : Age>60, CKD, CHF ... fluid balance, and CXR ... with pulmonary
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... Typical symptoms: dyspnea ... paroxysmal noctumal dyspnea ... → no signs of CXR ... diagnosis #management #cardiology
On the left another patient with alveolar edema at admission, which resolved after treatment.
When you scroll
resolved after treatment ... distribution of pulmonary ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... #heartfailure #chf ... #pharmacology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... May have typical HF ... sx: dyspnea on ... diagnosis #management #cardiology ... #treatment
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
• Cough • Dyspnea ... ratio ≤250 • Hypotension ... aeruginosa Clinical ... Yield of blood CX ... #Pulmonary #Community
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... , hypokalemia, hypertension ... tolerable • Limited clinical ... fever, chills, dyspnea ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... Weaknesses: Limited clinical ... fever, chills, dyspnea ... Coccidioidomycosis #pharmacology ... #management #treatment
Stage III - Alveolar edema
This stage is characterized by continued fluid leakage into the interstitium, which
admitted with severe dyspnoe ... After treatment ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema